Melinamide

Other Notes Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of rare and unique chemicals. Sigma-Aldrich does not collect analytical data for this product.

Application (E/Z)-BCI hydrochloride has been used: to evaluate the role of the Duox-H 2 O 2 -Dusp6 derepression signaling pathway in heart regeneration as an MKP-1 inhibitor to investigate the role of MKP-1 on bexarotent-induced effects as a dual

Application (E/Z)-BCI hydrochloride has been used: to evaluate the role of the Duox-H 2 O 2 -Dusp6 derepression signaling pathway in heart regeneration as an MKP-1 inhibitor to investigate the role of MKP-1 on bexarotent-induced effects as a dual

Application Chiral building block in the enantioselective syntheses of hydroxyisoxazolidines and (+)- cis -sylvaticin, a potential antitumor agent. Used in the total synthesis of Macquarimicins and in the total synthesis of the macrolide RK-397.

Application Chiral building block in the enantioselective syntheses of hydroxyisoxazolidines and (+)- cis -sylvaticin, a potential antitumor agent. Used in the total synthesis of Macquarimicins and in the total synthesis of the macrolide RK-397.

Other Notes Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of rare and unique chemicals. Sigma-Aldrich does not collect analytical data for this product.

Anti-LAMTOR5 late endosomal/lysosomal adaptor, MAPK and MTOR

General description The protein encoded by this gene belongs to the NR1 subfamily of the nuclear receptor superfamily. The NR1 family members are key regulators of macrophage function, controlling transcriptional programs involved in lipid

Anti-RIMKLA ribosomal modification protein rimK-like family

BMS-986235 (LAR-1219) is a selective, orally active formyl peptide receptor 2 (FPR2) agonist, with EC 50 s of 0.41 nM and 3.4 nM for hFPR2 and mFPR2, respectively. BMS-986235 has potential for the prevention of heart failureIn VitroBMS-986235

BMS-986235 (LAR-1219) is a selective, orally active formyl peptide receptor 2 (FPR2) agonist, with EC 50 s of 0.41 nM and 3.4 nM for hFPR2 and mFPR2, respectively. BMS-986235 has potential for the prevention of heart failureIn VitroBMS-986235

BMS-986235 (LAR-1219) is a selective, orally active formyl peptide receptor 2 (FPR2) agonist, with EC 50 s of 0.41 nM and 3.4 nM for hFPR2 and mFPR2, respectively. BMS-986235 has potential for the prevention of heart failureIn VitroBMS-986235